Latest News

Revenue Optimization: The Money Matters—That Matter Most
Revenue Optimization: The Money Matters—That Matter Most

May 9th 2025

Navigating technology and regulatory shifts in pharma revenue management.

FDA Grants Accelerated Approval to Verastem Oncology’s Avmapki Fakzynja Co-Pack for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
FDA Grants Accelerated Approval to Verastem Oncology’s Avmapki Fakzynja Co-Pack for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer

May 9th 2025

Bridging the Gap:  A Large Pharma Blueprint
Bridging the Gap: A Large Pharma Blueprint

May 9th 2025

Hybrid Hub Models for the Patient Journey
Hybrid Hub Models for the Patient Journey

May 9th 2025

GLP-1 Drug Repurposing for Addiction Disorders Hampered by High Costs and Legal Hurdles
GLP-1 Drug Repurposing for Addiction Disorders Hampered by High Costs and Legal Hurdles

May 9th 2025

The 2025 Pharmaceutical Executive APEX Awards

You deserve the spotlight. Your work educates, informs, and empowers decisions that save lives—and now it’s time for the industry to take notice.

You deserve the spotlight. Your work educates, informs, and empowers decisions that save lives — and now it’s time for the industry to take notice.

Conference Coverage

View All
Asembia 2025: GLP-1 Drugs Reshape Reimbursement and Coverage Models
Asembia 2025: GLP-1 Drugs Reshape Reimbursement and Coverage Models

May 7th 2025

Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support
Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support

May 7th 2025

Asembia 2025: Digital Health and Biosimilars Shape the Future of Pharmacy
Asembia 2025: Digital Health and Biosimilars Shape the Future of Pharmacy

May 6th 2025

Asembia 2025: Tracking Long-Term Outcomes Key to Advanced Therapy Value
Asembia 2025: Tracking Long-Term Outcomes Key to Advanced Therapy Value

May 6th 2025

Latest Videos
Podcasts
Peter Ax, UpScriptHealth
Jennifer Butler

All News